Bolt Biotherapeutics, Inc. Common Stock (NASDAQ: BOLT) last traded at $4.11, up 13.22% on the session. The quote above updates while this page is open; the figures below are drawn from Bolt Biotherapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Bolt Biotherapeutics, Inc. Common Stock trades on NASDAQ under the ticker BOLT. Its market capitalisation is $7.92 million.
Valuation measures for Bolt Biotherapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $7.92M |
|---|---|
| Enterprise value | $22.76M |
| Price / sales | 1.68 |
| Price / book | 0.63 |
| Beta | 0.76 |
Trailing-twelve-month figures tagged in Bolt Biotherapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $4.70M |
|---|---|
| Net income (TTM) | -$28.74M |
| EPS (TTM) | -$16.51 |
| Operating margin | -654.53% |
| Return on equity | -227.37% |
| Cash | $12.86M |
Range and volume for BOLT over the past 52 weeks.
| 52-week high | $7.20 |
|---|---|
| 52-week low | $3.10 |
| Volume | 87.2K |
| Average volume | 27.2K |
| Previous close | $3.63 |
Invest a chosen dollar amount in Bolt Biotherapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BOLT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.